论文部分内容阅读
血栓形成在临床上是一种常见的多发病,它的形成与纤溶系统和血小板功能异常有关。组织型纤溶酶原激活剂(Tissue Plasminogen Activator, t-PA)及其抑制剂(Plasminogen Activator Inhibitor, PAI)主要由血管内皮细胞(VEC)合成、贮存并释放入血,两者是体内纤溶系统的主要调节物质。β血栓球蛋白(β-Thromboglobulin, β-TG)是血
Thrombosis is clinically a common and frequently occurring disease, and its formation is related to fibrinolytic system and abnormal platelet function. Tissue Plasminogen Activator (t-PA) and its Plasminogen Activator Inhibitor (PAI) are mainly synthesized by vascular endothelial cells (VECs), stored and released into the blood, both of which are fibrinolytic The main regulatory substance of the system. β-Thromboglobulin (β-TG) is blood